Last Close
Mar 17  •  04:00PM ET
3.00
Dollar change
+0.08
Percentage change
2.74
%
Index- P/E27.15 EPS (ttm)0.11 Insider Own11.31% Shs Outstand10.64M Perf Week-26.65%
Market Cap31.93M Forward P/E23.08 EPS next Y0.13 Insider Trans0.00% Shs Float9.44M Perf Month-26.83%
Enterprise Value27.59M PEG- EPS next Q0.01 Inst Own49.81% Short Float0.04% Perf Quarter-40.24%
Income1.19M P/S1.70 EPS this Y-45.45% Inst Trans2.82% Short Ratio0.08 Perf Half Y-31.19%
Sales18.79M P/B3.13 EPS next Y116.67% ROA9.61% Short Interest0.00M Perf YTD-38.52%
Book/sh0.96 P/C5.91 EPS next 5Y- ROE12.71% 52W High6.42 -53.27% Perf Year86.16%
Cash/sh0.51 P/FCF19.35 EPS past 3/5Y- - ROIC10.98% 52W Low1.49 102.02% Perf 3Y175.23%
Dividend Est.- EV/EBITDA21.39 Sales past 3/5Y23.50% 17.02% Gross Margin61.13% Volatility8.49% 8.67% Perf 5Y-57.92%
Dividend TTM- EV/Sales1.47 EPS Y/Y TTM1531.88% Oper. Margin6.10% ATR (14)0.32 Perf 10Y-8.68%
Dividend Ex-Date- Quick Ratio2.89 Sales Y/Y TTM32.67% Profit Margin6.35% RSI (14)31.12 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio4.06 EPS Q/Q-83.38% SMA20-21.16% Beta1.54 Target Price7.00
Payout0.00% Debt/Eq0.10 Sales Q/Q22.20% SMA50-28.25% Rel Volume1.69 Prev Close2.92
Employees36 LT Debt/Eq0.07 EarningsMar 12 AMC SMA200-31.14% Avg Volume49.62K Price3.00
IPOSep 21, 2004 Option/ShortNo / Yes EPS/Sales Surpr.0.00% 6.25% Trades Volume83,685 Change2.74%
Date Action Analyst Rating Change Price Target Change
Jan-26-21Initiated B. Riley Securities Buy $12.50
Mar-13-26 09:02PM
08:30AM
Mar-12-26 04:10PM
Mar-05-26 07:04AM
Feb-13-26 08:16AM
09:00AM Loading…
Dec-11-25 09:00AM
Nov-10-25 08:04PM
Nov-06-25 04:10PM
Oct-30-25 04:00PM
Oct-08-25 09:00AM
Oct-07-25 10:41AM
Aug-08-25 11:00PM
Aug-07-25 04:00PM
Jul-31-25 04:00PM
Jul-15-25 09:19AM
09:00AM Loading…
May-28-25 09:00AM
May-08-25 04:00PM
May-07-25 11:46AM
Apr-30-25 04:00PM
Apr-28-25 09:00AM
Mar-06-25 04:00PM
Mar-05-25 07:36AM
Feb-26-25 04:00PM
Dec-04-24 09:00AM
Nov-08-24 04:03PM
Nov-07-24 04:01PM
Nov-06-24 07:56AM
Oct-31-24 07:30AM
Oct-25-24 09:10AM
Oct-24-24 09:00AM
09:00AM Loading…
Oct-17-24 09:00AM
Oct-09-24 05:56PM
Aug-08-24 04:01PM
Aug-01-24 07:30AM
May-09-24 04:15PM
May-02-24 07:30AM
Apr-29-24 09:00AM
Apr-23-24 07:30AM
Mar-08-24 01:01PM
Mar-07-24 04:15PM
Feb-29-24 04:30PM
Nov-11-23 12:41PM
Nov-08-23 04:15PM
Nov-01-23 07:30AM
Oct-25-23 07:30AM
Sep-19-23 04:30PM
Aug-09-23 04:15PM
Jul-26-23 07:30AM
May-24-23 07:30AM
May-10-23 04:15PM
May-08-23 07:30AM
Apr-26-23 07:30AM
Apr-04-23 07:30AM
Mar-08-23 04:15PM
Mar-01-23 04:30PM
Feb-22-23 04:30PM
Jan-11-23 07:30AM
Nov-02-22 04:15PM
Oct-19-22 07:30AM
Oct-12-22 07:30AM
Oct-11-22 07:30AM
Sep-28-22 07:30AM
Sep-08-22 04:00PM
Aug-13-22 08:22AM
Aug-10-22 04:15PM
Jul-27-22 07:30AM
Jul-06-22 07:30AM
May-17-22 07:30AM
May-04-22 04:15PM
Apr-27-22 07:30AM
Apr-26-22 07:30AM
Mar-21-22 07:30AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Feb-09-22 07:30AM
Jan-13-22 07:30AM
Jan-11-22 07:30AM
Nov-23-21 04:15PM
Nov-08-21 07:30AM
Nov-04-21 04:15PM
Oct-21-21 07:30AM
Oct-08-21 07:30AM
Oct-05-21 07:30AM
Sep-15-21 09:39AM
Sep-06-21 11:42AM
Sep-01-21 07:30AM
Aug-05-21 04:15PM
Jul-28-21 03:03PM
Jul-12-21 07:30AM
Jul-09-21 04:18PM
Jul-08-21 11:20AM
07:30AM
05:07AM
Jun-29-21 08:50AM
Jun-23-21 09:35AM
May-31-21 08:50AM
May-06-21 04:15PM
02:45PM
Apr-26-21 07:30AM
Apr-09-21 05:29AM
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.